Wednesday, September 23, 2026

Why Strokes Spike When Temperatures Drop—And How You Can Protect Yourself

Sudden temperature drops can increase stroke risk. Quick intervention is crucial for treatment and prevention of cerebrovascular diseases.

North Korean Women’s Soccer Team Starts South Korea Entry Process for Suwon Match

North Korean women's soccer team 'Hometown Team' begins entry procedures for South Korea visit to compete in AFC Women's Champions League.

How Kim Jong Un’s Construction Drive is Shaping North Korea’s Future: A Shift from Military to Civil Leadership

Kim Jong Un's focus on construction reflects a shift to a governance style prioritizing visible achievements over military displays.

Health

Dementia vs. Normal Aging: How to Spot the Differences and Take Action

September 21 is Dementia Overcoming Day, highlighting that dementia affects all age groups due to rapid aging.

Semaglutide and NAION: What Recent Research Reveals About Your Eye Health

Controversy surrounds the rare vision abnormalities linked to semaglutide, the key ingredient in Wegovy and Ozempic.

NeogenLogic Receives U.S. Patent Decision for AI Technology to Identify Cancer Vaccine Targets

SCL Science subsidiary NeogenLogic has received a decision to grant a U.S. patent for technology that uses artificial intelligence to identify cancer targets most likely to trigger an immune response in individual patients.

HLB Cholangiocarcinoma Drug FDA Decision Due in 3 Days: No Additional Review Issues Reported

HLB’s bile duct cancer drug lirafugratinib is three days away from its FDA decision, with no additional review or manufacturing-site issues reported so far, keeping attention focused on the U.S. approval outcome.

Lecanemab Shows Manageable Safety Profile in Korean Patients

A real-world analysis of Korean patients treated with lecanemab found that most infusion-related reactions and amyloid-related imaging abnormalities (ARIA) were mild or asymptomatic, while baseline MRI assessment and regular monitoring remained important.
Latest

Daewoong Pharma Unveils First Patient Data From Phase 2 Trial of Pulmonary Fibrosis Drug Bersiporocin

Daewoong Pharmaceutical has presented baseline characteristics for all 104 patients enrolled in the global Phase 2 trial of bersiporocin, its investigational treatment for idiopathic pulmonary fibrosis

Matica Bio Partners With Bondwell Technologies to Develop Next-Generation Protein Manufacturing Processes

Matica Bio, the U.S. subsidiary of CHA Biotech, will provide process optimization services to Bondwell Technologies to support production and commercialization of next-generation protein biomaterials.

From Research Breakthroughs to New Drugs: Helping K-Drug Candidates Reach Global Markets

South Korea is strengthening support across the commercialization process to help domestically discovered drug candidates move beyond licensing deals and become globally developed medicines.

I Started a Company to Solve Patient Problems. For This Doctor-Founder, It Took Seven Years to Break Through

AITRICS CEO Kim Kwang-jun spent seven to eight years turning a clinical need he identified as a geriatrician into an AI medical product that could actually be used in hospitals.

ST Pharm Secures Record $66.1 Million Oligonucleotide API Supply Contract

ST Pharm has won a $66.1 million oligonucleotide drug substance supply contract from a global U.S.-based biotech company, marking its largest single oligonucleotide contract to date.

Unlocking the Future: How IVL3004’s Monthly Injection Revolutionizes Addiction Treatment

Inventage Lab receives U.S. patent approval for a monthly drug addiction treatment, aiming for clinical trials and global commercialization.

HLB’s LYRFIGTU: What Does FDA’s Conditional Acceptance Mean for Biliary Cancer Treatment?

HLB's new bile duct cancer drug candidate, Liraglutide, is expected to be named LYRFIGTU in the U.S., with FDA approval on September 25.

GCC2005: Breakthrough CAR-NK Therapy Shows 62.5% Response Rate in Clinical Trial

GC Cell announced interim results of its clinical trial for GCC2005 (CD5 CAR-NK) presented at ICBMT 2026 on September 17.

2026 Citizen Human Rights Award: Honoring Activism and Legal Excellence in South Korea

Human rights advocate Sek Al Mamoon and the Korean Women's Labor Association recognized for their work on migrant workers and refugee issues.

K-Medical Excellence: How Seoul Asan Hospital Dominates Global Rankings in 2027

Major South Korean hospitals ranked among the world's best specialized hospitals, showcasing the competitiveness of K-Medicine.

97-Year-Old Cancer Survivor Thrives After Robotic Surgery: A Breakthrough in Elderly Care

A 97-year-old gastric cancer patient received robotic surgery from Professor Kim at Catholic University, expressing heartfelt gratitude for a new lease on life.

Alteogen Wins Japanese Marketing Approval for Keytruda SC Using ALT-B4

Alteogen has secured Japanese manufacturing and marketing approval for MSD’s subcutaneous Keytruda formulation using Alteogen’s ALT-B4 technology, expanding the drug’s global commercialization footprint.

Lunit Named One of TIME’s World’s Best HealthTech Companies 2026

South Korean medical AI company Lunit has been named one of TIME’s World’s Best HealthTech Companies 2026, earning recognition in the Diagnostics category for its global presence and competitiveness in AI-powered medical imaging.

Dongkoo Bio&Pharma Enters Hearing Health Supplement Market With Strategic Investment in Invivotech

Dongkoo Bio&Pharma is entering the hearing health market through a strategic investment in Invivotech and a partnership to develop and commercialize a functional health supplement ingredient designed to help maintain hearing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.